Abstract:For the surgical treatment of coronary artery disease, renal artery stenosis and other peripheral vascular diseases, there is significant demand for small diameter (inner diameter <6 mm) vascular grafts. However, autologous grafts are not always available when the substitute vascular grafts are severely diseased. In our previous work, hybrid small-diameter vascular grafts were successfully fabricated by combining electrospun polycaprolactone (PCL) and decellularized rat aorta (DRA). However, histological assessments of these grafts revealed the development of intimal hyperplasia, indicating potential negative impacts on the long-term patency of these grafts. To address this challenge, PCL nanofibers blended with rapamycin (RM) were electrospun outside the decellularized vascular graft to fabricate a RM-loaded hybrid tissue-engineered vascular graft (RM-HTEV), endowing the graft with a drug delivery function to prevent intimal hyperplasia. RM-HTEV possessed superior mechanical properties compared to DRA and exhibited a sustained drug release profile. To evaluate the applicability of RM-HTEV in vivo, abdominal aorta transplantation was performed on rats. Doppler sonography showed that the grafts were functional for up to 8 weeks in vivo. Moreover, histological analysis of explanted grafts 12 weeks postimplantation demonstrated that RM-HTEV significantly decreased neo-intimal hyperplasia compared with HTEV, without impairing reendothelialization and M2 macrophage polarization. Overall, RM-HTEV represents a promising strategy for developing small-diameter vascular grafts with great clinical translational potential. STATEMENT OF SIGNIFICANCE: In this study, a new type of rapamycin-loaded hybrid tissue-engineered vascular graft (RM-HTEV) was fabricated using electrospinning technology. The unique hybrid bi-layer structure endowed the RM-HTEV with multi-functionality: the exterior rapamycin-loaded electrospun PCL nanofibrous layer enhanced the mechanical properties of the graft and possessed drug releasing property; the interior decellularized aorta layer with porous structure could facilitate cell proliferation and migration. In in vivo implantation experiment, RM-HTEV exhibited satisfying long-term patency rate and significantly inhibited intimal hyperplasia without impairing re-endothelialization and M2 macrophage polarization. This strategy is expected to be a promising strategy for developing bioactive small-diameter vascular grafts with great clinical translational potential.

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins

Development of 3D-bioprinted artificial blood vessels loaded with rapamycin-nanoparticles for ischemic repair

Patient-specific 3D in vitro modeling and fluid dynamic analysis of primary pulmonary vein stenosis

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Directly Coaxial 3D Bioprinting of Large-Scale Vascularized Tissue Constructs.

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Computational modeling of in-stent restenosis: Pharmacokinetic and pharmacodynamic evaluation

Coaxial bioprinting of a stentable and endothelialized human coronary artery-sized in vitro model

3D-bioprinted cell-laden blood vessel with dual drug delivery nanoparticles for advancing vascular regeneration

3D bioprinting of prevascularised implants for the repair of critically-sized bone defects

3d Elastomeric Stent Functionalized with Antioxidative And Perivascular Tissue Regenerative Activities Ameliorated Pvt Deprivation‐Induced Vein Graft Failure

Nanoparticle-based Approaches for Treating Restenosis after Vascular Injury

3D bioprinting strategy for engineering vascularized tissue models

Three-Dimensional Virtual Surgery Models for Percutaneous Coronary Intervention (pci) Optimization Strategies

In Vitro and in Vivo Evaluation of Rapamycin-eluting Nanofibers Coated on Cardia Stents

Bioprinting of Perfusable Vascularized Organ Models for Drug Development via Sacrificial‐Free Direct Ink Writing

Direct 3D printing of thin-walled cardiovascular stents with negative Poisson's ratio (NPR) structure and functional metallic coating

In Vitro and in Vivo Evaluation of 3D Bioprinted Small-Diameter Vasculature with Smooth Muscle and Endothelium.

3D Bioprinting for Vascularization

3D-Printed Proangiogenic Patches of Photo-Crosslinked Gelatin and Polyurethane Hydrogels Laden with Vascular Cells for Treating Vascular Ischemic Diseases

Hybrid Electrospun Rapamycin-Loaded Small-Diameter Decellularized Vascular Grafts Effectively Inhibit Intimal Hyperplasia